Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Myra Gilligan is active.

Publication


Featured researches published by Myra Gilligan.


Bioorganic & Medicinal Chemistry Letters | 2010

Non-basic ligands for aminergic GPCRs: the discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders.

Tammy Ladduwahetty; Myra Gilligan; Alexander Charles Humphries; Kevin John Merchant; Rebecca L. Fish; George McAlister; Magnus Ivarsson; María Domínguez; Desmond O’Connor; Angus Murray Macleod

Scaffold hopping from a non-basic series of 5-HT(2A) receptor antagonists developed in-house that possessed reduced activity in vivo enabled the discovery of a novel series of diaryl sulfones that gave excellent occupancy on oral dosing. Not only does this work further demonstrate that oral bioavailability of a given series can be enhanced by improving physicochemical parameters such as log P, but it corroborates the growing evidence that a protonated amine is not essential for affinity at aminergic GPCRs.


Bioorganic & Medicinal Chemistry Letters | 2006

8-Fluoroimidazo[1,2-a]pyridine: Synthesis, physicochemical properties and evaluation as a bioisosteric replacement for imidazo[1,2-a]pyrimidine in an allosteric modulator ligand of the GABAA receptor

Alexander Charles Humphries; Emanuela Gancia; Myra Gilligan; Simon Charles Goodacre; David James Hallett; Kevin John Merchant; Steve Thomas


Bioorganic & Medicinal Chemistry Letters | 2005

4-Fluorosulfonylpiperidines: selective 5-HT2A ligands for the treatment of insomnia.

L. Rebecca Fish; Myra Gilligan; Alexander Charles Humphries; Magnus Ivarsson; Tammy Ladduwahetty; Kevin John Merchant; Desmond O’Connor; Smita Patel; Elisabeth Philipps; Hugo M. Vargas; Peter H. Hutson; Angus Murray Macleod


Archive | 2005

Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists

Mark Stuart Chambers; Neil Roy Curtis; Emanuela Gancia; Myra Gilligan; Alexander Charles Humphries; Tamara Ladduwahetty; Robert James Maxey; Kevin John Merchant


Archive | 2006

Heteroarylsulfonyl Stilbenes as 5-Ht2a Antagonists

Myra Gilligan; Alexander Charles Humphries; Tamara Ladduwahetty; Kevin John Merchant


Archive | 2006

Arylsulfonyl benzyl ethers as 5-ht2a antagonists

Mark Stuart Chambers; Myra Gilligan; Alexander Charles Humphries; Kevin John Merchant


Archive | 2007

Diarylsulfones as 5-HT2A antagonists

Jose Luis Castro Pineiro; Laura Catherine Cooper; Myra Gilligan; Alexander Charles Humphries; Peter Hunt; Tamara Ladduwahetty; Angus Murray Macleod; Kevin John Merchant; Monique Bodil Van Niel; Kevin J. Wilson


Archive | 2004

4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor

Myra Gilligan; Alexander Charles Humphries; Tamara Ladduwahetty


Archive | 2007

Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions

Myra Gilligan; Alexander Charles Humphries; Peter Hunt; Tamara Ladduwahetty; Angus Murray Macleod; Kevin John Merchant


Archive | 2006

Ethers arylsulfonyle benzyle utilises en tant qu'antagonistes 5-ht2a

Mark Stuart Chambers; Myra Gilligan; Alexander Charles Humphries; Kevin John Merchant

Researchain Logo
Decentralizing Knowledge